-
shares in
Myovant, a
former Roivant subsidiary it was
previously a
majority owner of,
valuing the
company at $2.9B.
Following the
Myovant acquisition...
-
Pharma and
transferred its
ownership stake in five of its subsidiaries:
Myovant Sciences,
Urovant Sciences,
Enzyvant Therapeutics,
Altavant Sciences, and...
- PMC 4667159. PMID 26502357. "Relugolix -
Myovant/Takeda". AdisInsight.
Springer Nature Switzerland AG. "
Myovant Provides Corporate Updates and
Reports Financial...
- Agency.
Reproduction is
authorized provided the
source is acknowledged. "
Myovant Sciences and
Pfizer Receive U.S. FDA
Approval of Myfembree, a Once-Daily...
- Metabolism. 11 (6): 494–506. doi:10.2174/138920010791636211. PMID 20540693. "
Myovant Sciences and
Pfizer Receive U.S. FDA
Approval of Myfembree, a Once-Daily...
-
Archived from the
original on 2019-01-03.
Retrieved 2019-01-02. "Relugolix -
Myovant/Takeda". AdisInsight.
Springer Nature Switzerland AG.
Archived from the...
-
companies Sumitomo Pharma America Holdings, Inc.,
Sumitovant Biopharma Ltd.,
Myovant Sciences, Inc.,
Urovant Sciences, Inc.,
Enzyvant Therapeutics, Inc., and...
- Eli Lilly, Forendo,
Astellas Pharm,
Acella Pharmaceuticals, Scynexis,
Myovant Sciences,
Avion Pharmaceuticals, L'Oréal,
Cosmetique Active, Vichy, Peppy...
- 51 (23): 7478–85. doi:10.1021/jm8006454. PMID 19006286. "Relugolix -
Myovant/Takeda - AdisInsight".
Archived from the
original on 2018-09-20. Retrieved...
-
Sierra Point was
removed in 1983.
Aimmune Therapeutics Ideaya Biosciences Myovant Sciences Sangamo Therapeutics Ultragenyx Kezar Life
Sciences Tizona Therapeutics...
